EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism

Robert S Zhang, Muhammad H Maqsood, Andrew S P Sharp, Radu Postelnicu, Sanjum S Sethi, Allison Greco, Carlos Alviar, Sripal Bangalore

JACC: Cardiovascular Interventions · 2023-11 · 16 (21) · 2644-2651

DOI: 10.1016/j.jcin.2023.07.042 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JACC: Cardiovascular Interventions, 2023-11. Verfasst von Robert S Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Pulmonary Embolism, Thrombolytic Therapy. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The optimal treatment strategy of patients with pulmonary embolism (PE) (especially those with intermediate risk) continues to evolve and remains controversial. OBJECTIVES: This study sought to compare the efficacy and safety of anticoagulation (AC) alone, catheter-directed thrombolysis (CDT), and systemic thrombolysis (ST) in patients with acute PE. METHODS: PubMed and EMBASE were searched for randomized controlled trials or observational studies which compared outcomes of AC alone, CDT, and ST in acute PE. Efficacy outcome was all-cause mortality. Safety outcomes were major bleeding and intracranial hemorrhage (ICH). RESULTS: We identified 45 studies (17 randomized controlled trials, 2 prospective nonrandomized trials, and 26 retrospective observational trials), which included 81,705 patients. When compared with AC alone, CDT had lower mortality (OR: 0.55; 95% CI: 0.39-0.80) but higher major bleeding (OR: 1.84; 95% CI: 1.10-3.08) and numerically higher ICH (OR: 1.51; 95% CI: 0.75-3.04). ST was associated with no difference in mortality but higher major bleeding (OR: 2.16; 95% CI: 1.38-3.38) and ICH (OR: 2.26; 95% CI: 1.14-4.48) when compared with AC alone. The risk of mortality (OR: 2.05; 95% CI: 1.46-2.89) and ICH (OR: 1.50; 95% CI: 1.13-1.99) was higher with ST when compared with CDT. Findings were similar when analysis was restricted to trials of intermediate risk PE. CONCLUSIONS: In patients with acute PE, when compared with AC alone, CDT was associated with a lower mortality but higher risk of bleeding. Moreover, CDT had an enhanced safety profile when compared with ST.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismThrombolytic TherapyHumansAnticoagulantsCathetersFibrinolytic AgentsHemorrhageIntracranial HemorrhagesProspective StudiesRetrospective StudiesTreatment OutcomeRandomized Controlled Trials as TopicObservational Studies as Topic

Stichwörter der Autor:innen

anticoagulationcatheter-directed thrombolysisnetwork meta-analysispulmonary embolismsystemic thrombolysis

Substanzen

AnticoagulantsFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Medicine, Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, New York, New York, USA.
  • Department of Cardiology, DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA.
  • University Hospital of Wales, Cardiff University, Cardiff, United Kingdom.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Bellevue Hospital, NYU Grossman School of Medicine, New York, USA.
  • Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York, USA.
  • Department of Medicine, Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, New York, New York, USA. Electronic address: sripalbangalore@gmail.com.

Zitieren

APA

Zhang, R. S., Maqsood, M. H., Sharp, A. S. P., Postelnicu, R., Sethi, S. S., Greco, A., Alviar, C., & Bangalore, S. (2023). Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism. JACC: Cardiovascular Interventions, 16(21), 2644-2651. https://doi.org/10.1016/j.jcin.2023.07.042

Vancouver

Zhang RS, Maqsood MH, Sharp ASP, Postelnicu R, Sethi SS, Greco A, et al. Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism. JACC: Cardiovascular Interventions. 2023;16(21):2644-2651. doi:10.1016/j.jcin.2023.07.042

BibTeX
@article{Zhang2023,
  author = {Zhang, Robert S and Maqsood, Muhammad H and Sharp, Andrew S P and Postelnicu, Radu and Sethi, Sanjum S and Greco, Allison and Alviar, Carlos and Bangalore, Sripal},
  title = {Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism},
  journal = {JACC: Cardiovascular Interventions},
  year = {2023},
  volume = {16},
  number = {21},
  pages = {2644--2651},
  doi = {10.1016/j.jcin.2023.07.042}
}
Kostenlos starten →